{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:47:10Z","timestamp":1786654030539,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007632","name":"Futaba Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008670","name":"Terumo Foundation for Life Sciences and Arts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008965","name":"Takahashi Industrial and Economic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012014","name":"Kieikai Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010742","name":"The Ogawa Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejphar.2026.179183","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:45:21Z","timestamp":1784961921000},"page":"179183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Elevation of anticancer drug-induced cytotoxicity by velpatasvir through downregulation of claudin-14 expression in human colorectal cancer cells"],"prefix":"10.1016","volume":"1031","author":[{"given":"Tomoka","family":"Ando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiemi","family":"Tosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7698-9378","authenticated-orcid":false,"given":"Kazushi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-2471","authenticated-orcid":false,"given":"Takehiro","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Shirouzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-9672","authenticated-orcid":false,"given":"Satoshi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Matsuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2696-0897","authenticated-orcid":false,"given":"Akira","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179183_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032676","article-title":"Leading edge: intratumor delivery of monoclonal antibodies for the treatment of solid tumors","volume":"24","author":"Blanco","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179183_bib2","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejphar.2026.179183_bib3","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkm276","article-title":"PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations","volume":"35","author":"Dolinsky","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179183_bib4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/emboj.2012.49","article-title":"Claudin-14 regulates renal Ca2+ transport in response to CaSR signalling via a novel microRNA pathway","volume":"31","author":"Gong","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2026.179183_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"Gunzel","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2026.179183_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094634","article-title":"Claudins in cancer: a Current and future therapeutic target","volume":"25","author":"Hana","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179183_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00424-016-1878-6","article-title":"Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers","volume":"469","author":"Hashimoto","year":"2017","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2026.179183_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1749-6632.2012.06529.x","article-title":"The yin and yang of claudin-14 function in human diseases","volume":"1258","author":"Hou","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2026.179183_bib9","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.3390\/ijms22126582","article-title":"Elevation of chemosensitivity of lung adenocarcinoma A549 spheroid cells by Claudin-2 knockdown through activation of glucose transport and inhibition of Nrf2 signal","volume":"22","author":"Ito","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179183_bib10","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5424","article-title":"Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer","volume":"54","author":"Katoh","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179183_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184579","article-title":"Detailed clinical features of deafness caused by a Claudin-14 variant","volume":"20","author":"Kitano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179183_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231217967","article-title":"Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer","volume":"16","author":"Kubota","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejphar.2026.179183_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091469","article-title":"The role of Claudin-1 in enhancing pancreatic cancer aggressiveness and drug resistance via Metabolic Pathway modulation","volume":"17","author":"Kyuno","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.179183_bib14","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/AAC.00763-16","article-title":"Clinical resistance to Velpatasvir (GS-5816), a novel pan-genotypic inhibitor of the Hepatitis C virus NS5A protein","volume":"60","author":"Lawitz","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2026.179183_bib15","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.bmcl.2019.04.027","article-title":"Discovery of velpatasvir (GS-5816): a potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi((R)) and Epclusa((R))","volume":"29","author":"Link","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2026.179183_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179183_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117325","article-title":"FDA-approved antivirals ledipasvir and daclatasvir downregulate the Src-EPHA2-Akt oncogenic pathway in colorectal and triple-negative breast cancer cells","volume":"179","author":"Mezquita","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179183_bib18","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an Efficient Program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejphar.2026.179183_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30675","article-title":"Reduction of chemoresistance by Claudin-14-Targeting peptide in human colorectal cancer cells","volume":"126","author":"Mizukami","year":"2025","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2026.179183_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110075","article-title":"Downregulation of chemoresistance by claudin-14 silencing in human colorectal cancer cells","volume":"758","author":"Mizukami","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2026.179183_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02084-16","article-title":"Preclinical pharmacokinetics and First-in-Human pharmacokinetics, safety, and tolerability of Velpatasvir, a pangenotypic hepatitis C virus NS5A Inhibitor, in healthy subjects","volume":"61","author":"Mogalian","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2026.179183_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.118642","article-title":"Claudin-2 binding peptides, VPDSM and DSMKF, down-regulate claudin-2 expression and anticancer resistance in human lung adenocarcinoma A549 cells","volume":"1867","author":"Nasako","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2026.179183_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165909","article-title":"Increase in toxicity of anticancer drugs by PMTPV, a claudin-1-binding peptide, mediated via down-regulation of claudin-1 in human lung adenocarcinoma A549 cells","volume":"21","author":"Nasako","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179183_bib24","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/bioinformatics\/bts186","article-title":"e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design","volume":"28","author":"Pihan","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2026.179183_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317705510","article-title":"The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance","volume":"39","author":"Sadeghi","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ejphar.2026.179183_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179183_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep30442","article-title":"Cell-free methods to produce structurally intact mammalian membrane proteins","volume":"6","author":"Shinoda","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179183_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep33632","article-title":"Structural basis for disruption of claudin assembly in tight junctions by an enterotoxin","volume":"6","author":"Shinoda","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179183_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejphar.2026.179183_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2018.09.008","article-title":"The claudins: from tight junctions to biological systems","volume":"44","author":"Tsukita","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2026.179183_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1051497","article-title":"The role and mechanism of claudins in cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.179183_bib32","doi-asserted-by":"crossref","first-page":"10539","DOI":"10.3390\/ijms140510539","article-title":"NS5ATP9 contributes to inhibition of cell proliferation by hepatitis C virus (HCV) nonstructural protein 5A (NS5A) via MEK\/extracellular signal regulated kinase (ERK) pathway","volume":"14","author":"Wang","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179183_bib33","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179183_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10969-007-9038-z","article-title":"A robust two-step PCR method of template DNA production for high-throughput cell-free protein synthesis","volume":"8","author":"Yabuki","year":"2007","journal-title":"J. Struct. Funct. Genom."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:15:21Z","timestamp":1786652121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"alternative-id":["S0014299926006655"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179183","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevation of anticancer drug-induced cytotoxicity by velpatasvir through downregulation of claudin-14 expression in human colorectal cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179183"}}